The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery

Presentation information

Print

U-40 Oral

U-40 Oral 7
Pancreas 3

Sat. Jun 9, 2018 10:00 AM - 10:50 AM Room 4 (4F, 411+412)

Chairs: Masamichi Mizuma (Department of Surgery, Tohoku University), Junpei Yamaguchi (Nagoya University Graduate School of Medicine, Surgical Oncology)

[U40-7-1] The combined immunotherapy based on integrated immune ratio in pancreatic cancer delays tumor growth and enhances its prognosis

○Ning Pu (Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China)

The password is described in the Program Book.
Please refer to page 5.

Password